Report error Found 30 Enz. Inhib. hit(s) with all data for entry = 13594
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataKi: 2.20nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataKi: 2.90nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataKi: 3nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataKi: 3.70nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataKi: 4nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataIC50: 4nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataKi: 4.90nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataIC50: 5.30nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataIC50: 5.5nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataKi: 5.80nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataKi: 6.60nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataKi: 6.60nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataIC50: 6.80nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataKi: 7nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataKi: 7.30nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataIC50: 7.40nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataKi: 8.90nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataIC50: 9nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataIC50: 11nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataIC50: 12nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataIC50: 12nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataIC50: 13nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataIC50: 13nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataKi: 15nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataKi: 16nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataIC50: 16nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataKi: 17nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataIC50: 28nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataIC50: 30nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Affinity DataIC50: 31nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair














